|
1
|
Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery.
|
J Control Release
|
2005
|
1.32
|
|
2
|
Therapeutic peptides for cancer therapy. Part II - cell cycle inhibitory peptides and apoptosis-inducing peptides.
|
Expert Opin Drug Deliv
|
2009
|
1.05
|
|
3
|
Inhibition of ovarian cancer cell proliferation by a cell cycle inhibitory peptide fused to a thermally responsive polypeptide carrier.
|
Int J Cancer
|
2010
|
0.98
|
|
4
|
Slow assembly and disassembly of lambda Cro repressor dimers.
|
J Mol Biol
|
2005
|
0.88
|
|
5
|
A polypeptide drug carrier for maternal delivery and prevention of fetal exposure.
|
J Drug Target
|
2014
|
0.87
|
|
6
|
Thermally targeted delivery of chemotherapeutics and anti-cancer peptides by elastin-like polypeptide.
|
Expert Opin Drug Deliv
|
2008
|
0.86
|
|
7
|
Inhibition of ovarian cancer cell metastasis by a fusion polypeptide Tat-ELP.
|
Clin Exp Metastasis
|
2009
|
0.85
|
|
8
|
Structural and hydrodynamic analysis of a novel drug delivery vector: ELP[V5G3A2-150].
|
Biophys J
|
2013
|
0.78
|
|
9
|
Therapeutic angiogenesis by vascular endothelial growth factor supplementation for treatment of renal disease.
|
Curr Opin Nephrol Hypertens
|
2016
|
0.78
|
|
10
|
Effect of basic cell-penetrating peptides on the structural, thermodynamic, and hydrodynamic properties of a novel drug delivery vector, ELP[V5G3A2-150].
|
Biochemistry
|
2014
|
0.76
|
|
11
|
Nitroreductase-triggered activation of a novel caged fluorescent probe obtained from methylene blue.
|
Chem Commun (Camb)
|
2015
|
0.76
|
|
12
|
STOX1: a new player in preeclampsia?
|
Hypertension
|
2013
|
0.75
|
|
13
|
Safety and Pharmacokinetics of Intranasally Administered Heparin.
|
medRxiv
|
2022
|
0.75
|